Evidence map›Paper›PMID 23511897›Full record

Trial reportJournal of lipid research2013

High density lipoprotein as a source of cholesterol for adrenal steroidogenesis: a study in individuals with low plasma HDL-C.

Andrea E Bochem, Adriaan G Holleboom, Johannes A Romijn, Menno Hoekstra, Geesje M Dallinga-Thie, Mahdi M Motazacker, G Kees Hovingh, Jan A Kuivenhoven, Erik S G Stroes

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in Journal of lipid research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Trafficking of cholesterol from lipid droplets to mitochondria in bovine luteal cells: Acute control of progesterone synthesis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Andrea E BochemDepartments of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: a.e.bochem@amc.uva.nl.
Adriaan G HolleboomDepartments of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Johannes A RomijnDepartments of Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Menno HoekstraLeiden/Amsterdam Center for Drug Research, Leiden, The Netherlands.
Geesje M Dallinga-ThieDepartments of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands; Experimental Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Mahdi M MotazackerDepartments of Medicine, Academic Medical Center, Amsterdam, The Netherlands.
G Kees HovinghDepartments of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Jan A KuivenhovenDepartment of Pathology and Medical Biology, Department of Molecular Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Erik S G StroesDepartments of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Academic Medical Center · NLCentre for Human Drug Research · NLUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Few studies have addressed the delivery of lipoprotein-derived cholesterol to the adrenals for steroid production in humans. While there is evidence against a role for low-density lipoprotein (LDL), it is unresolved whether high density lipoprotein (HDL) contributes to adrenal steroidogenesis. To study this, steroid hormone profiles in urine were assessed in male subjects suffering from functional mutations in ATP binding cassette transporter A1 (ABCA1) (n = 24), lecithin:cholesterol acyltransferase (LCAT) (n = 40), as well as in 11 subjects with low HDL cholesterol (HDL-C) without ABCA1/LCAT mutations. HDL-C levels were 39% lower in the ABCA1, LCAT, and low HDL-C groups compared with controls (all P < 0.001). In all groups with low HDL-C levels, urinary excretion of 17-ketogenic steroids was reduced by 33%, 27%, and 32% compared with controls (all P < 0.04). In seven carriers of either type of mutation, adrenocorticotropic hormone (ACTH) stimulation did not reveal differences from normolipidemic controls. In conclusion, this study shows that basal but not stimulated corticosteroid metabolism is attenuated in subjects with low HDL-C, irrespective of its molecular origin. These findings lend support to a role for HDL as a cholesterol donor for basal adrenal steroidogenesis in humans.

Indexed as

Adrenal GlandsAdrenocorticotropic HormoneAdultAgedATP Binding Cassette Transporter 1ATP-Binding Cassette TransportersCholesterol, HDLHumansMaleMiddle AgedPhosphatidylcholine-Sterol O-AcyltransferaseSteroidsABCA1 protein, humanAdrenocorticotropic HormoneATP Binding Cassette Transporter 1ATP-Binding Cassette TransportersCholesterol, HDLPhosphatidylcholine-Sterol O-AcyltransferaseSteroidscortisoldyslipidemiahigh density lipoprotein cholesterolhypoalphalipoproteinemiasteroid hormones

Identifiers

PMID23511897
PMCPMC3646470
OpenAlexW2165275486

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.